相关实验视频
Updated: Jun 14, 2026
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
计算病理学识别了免疫介导的原干扰,以预测妇科恶性瘤的临床结果
Arpit Aggarwal1,2, Sirvan Khalighi2, Deepak Babu3
1Georgia Tech, Georgia, GA, USA.
Communications medicine
|January 3, 2024
概括
一种新的计算方法CollaTIL揭示了妇科瘤中增加的免疫细胞与混乱的原结构相关. 这一发现有助于理解瘤微环境的复杂性,并提供了新的预后见解.
科学领域:
- 计算病理学计算病理学
- 瘤微环境 (TME) 研究
- 妇科瘤学 妇科瘤学
背景情况:
- 免疫细胞,如瘤透性淋巴细胞 (TILs) 在TME内的原降解中的作用尚不清楚.
- 免疫细胞可以修改细胞外基质,影响癌症的进展和患者的生存.
- 对免疫细胞对TME原结构的影响的定量评估是有限的.
研究的目的:
- 引入CollaTIL,一种计算病理学方法,用于量化TME中的免疫 - 原关系.
- 为了研究免疫调节对妇科癌症中的原结构的影响.
- 揭示免疫系统和瘤进展之间的相互作用.
主要方法:
- 开发CollaTIL,一个计算病理学工具.
- 在TME中免疫原相互作用的定量表征.
- 对妇科癌症的分析:高度血清性卵巢癌 (HGSOC),子宫状细胞癌 (CSCC) 和子宫内膜癌.
主要成果:
- 增加的免疫透与混乱的原结构和TME中更高的度相关.
- 免疫稀疏的TME与有序的原和较低的有关.
- 与疾病风险分层相关的CollaTIL特征与特定的基因特征相关 (CSCC中的TCA循环;HGSOC中的氨基酸代谢和巨细胞).
结论:
- 在妇科癌症的TME中,CollaTIL显示了免疫透和原结构之间的显著关系.
- 将CollaTIL与基因组分析集成,为新的治疗策略提供了潜力.
- 这种方法在妇科瘤学中提供了增强的预后评估能力.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...